Shuddha Guggulu
By R. Javier. Bay Path College.
The main competitive advantages of the company are coordinated business behavior buy shuddha guggulu 60caps without a prescription weight loss 15 pounds, rich network of business contacts and relationship management skills discount 60caps shuddha guggulu free shipping ultra 90 weight loss pills, adaptation to change the unfavorable external environment, strategic flexibility, the use of programs of social partnership, innovation activity in solving social problems. Note that it is formed by the social partnership system allows the company to combine resources to create social programs that it cannot develop on their own. Human resources of cosmetic company is recruiting and retaining the necessary personnel corporation, his professional training and development, evaluation of each of the employees in terms of the implementation of the social objectives of the company, it gives the opportunity to adjust its behavior, and provides rewards for staff for his efforts. In their laboratory, scientists are creating new recipes and improve existing ones. Each year the company receives patents for ten or more cosmetic products, which are then used in production. The company has modern pharmaceutical equipment and cosmetic raw materials from leading manufacturers from France, Germany, Austria and other countries. Thus, the social management of modern perfumery and cosmetic companies - a system of social control that ensures the efficiency of the production of social production by addressing social problems in society and can effectively influence social processes in the country. We investigated the main aspects of the social management of modern enterprises perfume and cosmetic industry and found that the management model according to the system of social management provides a clear mission statement, goals and objectives for socially-directed enterprise perfumes and cosmetics, which affects the process of strategic planning, organization, motivation and evaluation practice. The pharmaceutical sector of health care isn‘t only one of the most significant, as it develops and manufactures medicines for maintenance and recovery of health, but also one of the most problem in economy, as it isn‘t able to ensure the availability of pharmaceutical care to all persons in need. A degree of participation of pharmaceutical companies in the work on increase in the availability of medicines and medical support is reflected by the rating indicator «The Access to Medicine Index» (than the bigger efforts a company applies to increase the availability of drugs and medicines in 106 low- and middle-income countries, the rating is the higher). A level of corporate social responsibility is reflected by a rating indicator «RepTrak® 100». It is the «gold standard» for measurement of reputation of the international companies, including pharmaceutical. The study of the major international rating indicators in the pharmaceutical industry and the identification of leaders among the pharmaceutical companies Materials and methods. During carrying out the research the data of Access to Medicine Index [http://www. The pharmaceutical branch in a rating «RepTrak® 100» in 2015 was presented by 10 international pharmaceutical companies, the leaders were «Johnson & Johnson», «Eli Lily», «Abbott Laboratories», «Novo Nordisk», «Bayer», «Bristol- Myers Squibb», «Roche», «Sanofi», «Merck Sharp & Dohme» и «AstraZeneca» (Table 2). Unfortunately, the companies «GlaxoSmithKline» and «Pfizer» in 2015 were not included into the top 100 of world leaders in the corporate social responsibility. Deregulation constantly brings changes with direct or potential impact on community pharmacies. For their understanding and positive use in provision an affordable and good quality pharmaceutical care, it is important to continuously monitor and analyse their development, particularly in relation to demographic and geographic characteristics. The number of community pharmacies, population to pharmacy ratio and area to pharmacy ratio are important parameters that are sensitive to changes with strong regulatory potential. Data on the number of public pharmacies, population, land area during the years 1998-2014, were drawn from a database of the Statistical Office of the Slovak Republic. Mann-Kendall test, Fisher test and Pettitt tests were carried out under the R statistical software. Gradually, increased the number of community pharmacies, concurrently the number of residents and the surface area per community pharmacy statistically significant decreased in all regions of Slovakia (p <0. Deregulation increased the number of community pharmacies and enhanced access to community pharmacies. Despite the fact, the public pharmacies were mostly established in major cities, we have recorded improvement of accessibility also in rural areas. It is therefore very important to correctly and promptly appoint a treatment every needy patient. The clinical protocol of diagnosis and treatment of psoriasis have more than 60 names of drugs. Study Objectives: To conduct a comparative analysis of the use of medicines in the diagnosis and treatment of psoriasis in a hospital. Results: The clinical protocol of diagnosis and treatment of psoriasis approved minutes of the meeting of the Expert Commission for the Development of Health number 18 by the Ministry of Health and Social Development of the Republic of Kazakhstan from September 19, 2013. This document specifies the treatment of two types of drugs for the treatment of psoriasis, the first - essential medicines (compulsory, 100% probability), the second is additional drugs (probability less than 100%).
In our view purchase shuddha guggulu 60caps without prescription weight loss lunch, the study pharmacy purchase shuddha guggulu 60 caps weight loss pills us, the figure was analyzed and planned in the first place. On average, the turnover increased by 7%, costs decreased by 3%, the imposition of trade decreased by 3. The analysis showed that 49% of the total cost goes to pay, 29% on social charges Article, all other expenses amounted to 22%. The analysis of dynamics of average study pharmaceutical firm costs for items of fixed costs has shown that most of the articles have increased slightly, while other expenses decreased. At the last stage of our research we calculated the main indicators studied pharmaceutical firm work. An analysis of these calculations showed that every year due to a decrease in the level of trade overlays profitability decreased to 0,8%, which is very low, but in 2015 the amount of profit by increasing turnover increased. We have found that trade study pharmacy during the analyzed period increased an average of 1,078 times (7. The analysis studied pharmaceutical firm allowed to confirm the constant growth of expenses. It was found that the largest share in the total expenditure of pharmaceutical firms serving the public are wage costs - 49. Currently, the organization of effective medical and pharmaceutical care of patients suffering from depressive disorder in Ukraine is of great socio-economic importance. The introduction of modern multimodal antidepressants into the treatment of patients with depressive disorders allows using them for a long time to achieve full recovery and supports the premorbidal level of social functioning. Innovative drug Vortioxytine corresponds to the important contemporary requirements which are put forward for the treatment of depression, has not only a high efficiency in relation to affective symptoms, but also unique properties to enhance cognitive functioning and, consequently, the quality of life of the patient. However, the application of new approaches is complicated by the problem of its high cost. To make the analyzes of "willingness-to-pay" in the organization of treatment of patients with depressive disorders in Ukraine. The object of the research was the survey data of psychiatrists (55 persons) and family members of patients with severe depression (75 people), which was conducted during 2015 in Zaporozhye. The questionnaire worked up for physicians consisted of two parts, in the first part it was necessary to specify personal data (age, place of work, position, work experience in the position, etc. The aim of the second unit was to establish the attitudes of respondents towards the "willingness-to- pay" at the expense from personal funds and rationality of the real cost of treatment with the drug Vortioxytine from the perspective of the health system as a whole. The purpose of questioning of other suffering from depressive disorders patients was to identify the "willingness-to-pay" opportunities by private funds (before that, the respondents indicated the average monthly income per 1 person in the family ), the rationality of the real costs for the treatment with the medicine Vortioxytine from the standpoint of the patient (indicating the cost of its implementation) and determining the maximum "willingness-to-pay" for the expense of personal budget and the rationality of the real costs from the position of health care organization. In the last decade, the results of pharmacoeconomic analysis is widely used in the health care system of the developed countries, while taking such management decisions as registration of medicinal products, development of forms and clinical guidelines (recommendations, standards of conducting patients), to draw up a restrictive list of medical technologies, whicn should to be paid from the expense budget or social insurance. The most valuable for the decision makers, are considered 205 the results of the analysis "cost-effectiveness" and "cost-utility". The analysis of "cost- benefit" remains quite attractive for economists in the field of health care organization because only it gives an indication of economic (monetary) benefit of the technologies contributing to the restoration, preservation or promotion of health. In addition, the results give us an insight into the preferences of the population (potential market) and at the same time can be used for economic justification of the use of medicines. Among others patients the proportion of responses to questions was higher than that among health care workers – to assess "willingness-to-pay" for the personal expense without knowing the cost of treatment with Vortioxytine could 91. After the respondents were informed about the cost of the treatment, to evaluate "willingness-to-pay" could only 79. The study calculated the ratio of the absolute difference of the benefits and costs depending on the size of «willingness-to-pay» for pharmaceutical ensure of different groups of respondents. If we consider the responses of doctors, the use of Vortioxytine is obviously beneficial. But taking into the consideration the opinion of the patients‘ significant additional monetary investment is needed. Evaluation of "willingness-to-pay" which was conducted among physicians showed that 51% of respondents believe that all the expense for the treatment are to be carried out by the health care budget. One of the important issues was to assess the feasibility of the real costs of Vortioxytine.
There was a small population of morphine-using addicts and some opium and cannabis smoking among artistic purchase shuddha guggulu 60caps overnight delivery weight loss pills 1990s, mystic and bohemian circles but the population of drug users at the beginning of the 20th century was relatively small buy shuddha guggulu 60caps without prescription weight loss pills quick. At the same time, British pharmacists and physicians had nearly 40 years’ experience of dispensing opiates and attempting to control their use. Britain became committed to a drug control policy as a result of the international narcotics control system established in the early 20th century. A series of international meetings, largely prompted by American concern about Far Eastern opiate use, laid the bases of the system. Britain’s involvement in the Indian opium trade with China through the 19th century was brought to an end by the Anglo-Chinese opium agreement. There was some domestic pressure for drug control, with public and press concern about cocaine smuggling to India and opium and morphine smuggling to the Far East, some of which involved British ships. This was of particular concern in the wartime emergency situation of 1915-1916 and was compounded by reports of cocaine use among soldiers, especially those on leave in London, which was seen as compromising army efficiency. In 1916, the Army Council issued an order prohibiting the gift or sale of cocaine and other drugs to soldiers, except on prescription. This was the first time that a doctor’s prescription was required by law for the purchase of specified drugs. The regulation made it an offence for anyone except physicians, pharmacists and vets to be in possession of, to sell or give cocaine. This Convention was the first global attempt at drug control and aimed to reduce the use of morphine and cocaine by restricting the manufacture of, trade in, distribution and use of, these drugs to ‘legitimate’ scientific and medical purposes only. Although it did not specify limiting the use of opium to scientific and medical purposes (and this was, essentially, not covered until 1961 – see Section 5. The Dangerous Drugs Act laid the foundation of further legislation and control policy in Britain and consolidated the precedence of the Home Office over the Ministry of Health in the area of drug policy. The Act generated little debate at large, with recent sensational accounts of recreational drug use among bohemian circles prompting a political and press demand for a penal approach to drug control. The population of opiate users at this time was small, largely middle class, addicted to morphine and in the medical and allied professions, or had become dependent in the course of medical treatment. At the suggestion of the Home Office, the Ministry of Health convened an expert committee (Departmental Committee on Morphine and Heroin Addiction) chaired by Sir Humphrey Rolleston, then President of the Royal College of Physicians, to consider and advise on the circumstances in which it was medically advisable to prescribe heroin or morphine to addicts. The report produced by the committee (usually known as the Rolleston Report),3 reaffirmed the doctor’s freedom to prescribe regular supplies of opioid drugs to certain addicted patients in defined circumstances that the committee regarded as ‘treatment’ rather than the ‘gratification of addiction’. While the possession of dangerous drugs without a prescription was still the subject of the criminal law, addiction to opioid drugs was recognised as the legitimate domain of medical practice (and hence prescribing). This balance of a medical approach within a penal framework became a hallmark of British drug control and has been called the ‘British System’ by commentators. The League of Nations was established after the First World War and provided a centralised body for administration of international drug control. The second Geneva Convention of 1925 was signed under the auspices of the League of Nations and required parties to the treaty to provide annual statistics on drug stocks and consumption, the production of raw opium and coca, and the manufacture and distribution of heroin, morphine and cocaine. The Geneva Convention was also notable in bringing cannabis under international control, and restrictions on cannabis were implemented in Britain with the 1928 Dangerous Drugs Act. This was a settled approach, as a major addiction problem was not apparent in the British drug scene. In the early 1960s, the first reports about the activities of young heroin users began to appear in British newspapers – a phenomenon that was new to Britain. The Home Office convened an interdepartmental committee under the chairmanship of Sir Russell Brain, largely prompted by concern about whether long-term prescribing was still appropriate more than 30 years after the Rolleston Report. The Brain Committee published its first report early in 1961,4 and concluded that the drug problem remained small and no changes in approach were needed. Increasing media and professional evidence of a heroin epidemic in Britain involving younger heroin users led to a Second Interdepartmental Committee on Drug Addiction, again chaired by Brain. Drug addiction was formulated as a ‘socially infectious condition’, for which it was appropriate to provide treatment. The committee concluded that the increase in heroin use had been fuelled by a small number of doctors who were overprescribing heroin and that individual doctors were unable to meet the demands of the new situation.
